Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19)

Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030946

Enrollment

Unknown

Registered

2020-03-19

Start date

2020-02-10

Completion date

Unknown

Last updated

2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

1:7/5000 Low molecular weight heparin therapy

2:The mechanical prevention

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with new coronavirus pneumonia and in need of hospitalization: they meet the diagnostic criteria of the diagnosis and treatment program for new coronavirus pneumonia (trial fifth edition) issued by the national health commission; 2. Pneumonia with novel coronavirus confirmed by aetiological nucleic acid test; 3. Aged 18 to 80 years; 4. Sign the informed consent; 5. VTE score was greater than or equal to 4, and there were no higher blood risk factors.

Exclusion criteria

Exclusion criteria: 1. Pregnant women or lactating women; 2. Severe liver function damage (child-pugh grade C); 3. Severe renal impairment (Ccr<=15ml/min); 4. Have any coexisting medical conditions or diseases that the investigator determines may impair the conduct of the study; 5. Social and mental disability, no legal capacity/restricted capacity; 6. Refuse to sign the informed consent; 7. VTE score <4; 8. Higher blood risk factors.

Design outcomes

Primary

Measure	Time frame
The biochemical indicators;	—

Countries

China

Contacts

Public ContactChunli Liu

The First Affiliated Hospital of Guangzhou Medical University

chunli@gird.cn+86 13560158649

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026